Pantoprazolo Pensa (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazolo Pensa, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazolo Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazolo Pensa is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosive lesions in the oesophagus. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with this rare endocrine disorder.

Pantoprazolo Pensa is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: occasional and mild. - Abdominal pain: non‑specific discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Acute interstitial nephritis: renal inflammation with possible reduced kidney function. - Severe hypersensitivity reactions: rash, angio‑edema, or anaphylaxis. - Osteoporosis‑related fractures: increased risk with long‑term use. - Vitamin B12 deficiency: reduced absorption leading to hematologic changes. - Hepatotoxicity: elevated liver enzymes or jaundice.

When prescribing Pantoprazolo Pensa, consider the following precautions: - Assess renal function: dose adjustment may be required in severe impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Monitor long‑term users: watch for bone density loss and vitamin B12 levels. - Review concomitant medications: potential for altered absorption of drugs requiring gastric acidity. - Pregnancy and lactation: use only if the potential benefit justifies the risk. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Pantoprazolo Pensa may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption due to increased gastric pH. - Atorvastatin: increased plasma concentrations, raising risk of myopathy. - Clopidogrel: diminished antiplatelet effect, potentially increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR values; regular coagulation monitoring recommended. - Methotrexate: reduced renal clearance may increase toxicity. - Digoxin: slight increase in serum levels; observe for signs of toxicity.